DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02257 SIRNAOMICS-B

Trading Add to Porfolio
Index Constituent : Stock Connect HK MS, Stock Connect HK S I
Major Shareholders Poon Hung Fai (16.44%)
Zhao Yan & Associates (10.79%)		 Sector Health Care & Biotechnology
Web Site http://www.sirnaomics.com Tel (852) 3180-9494
Email IR@sirnaomics.com Fax N/A
Related Equities N/A
Principal Activities The Company is an RNA therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of innovative drugs for indications with unmet medical needs and large market opportunities.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top